Americans may be overpaying for their prescription medicines nearly one-quarter of the time, although the average amount was relatively modest — less than $8. And there were more overpayments involving generic drugs than brand-name medicines, according to a new analysis.

Of about 9.5 million prescription insurance claims filed from January to June 2013, 2.2 million involved overpayments, and these totaled $135 million, or $10.51 per person, according to the analysis that was published in the Journal of the American Medical Association. And about 17 percent of the claims resulted in an overpayment exceeding $10.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • To quote the good Dr Gelad – ““I object to the term ‘overpayments.’
    Would she prefer ‘excessive charges’ or ‘apparent price gouging?’
    It’s all in a word …..

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy